Youcare Pharmaceutical Group Co., Ltd.

Equities

688658

CNE100005XQ2

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-15 pm EDT 5-day change 1st Jan Change
17.06 CNY +0.59% Intraday chart for Youcare Pharmaceutical Group Co., Ltd. -1.95% -18.22%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Youcare Pharma Gets Nod for Registration of Gastric Drug MT
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Youcare Pharmaceutical’s Antibiotic Passes Generic Drug Evaluation MT
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023. CI
Certain A Shares of Youcare Pharmaceutical Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-DEC-2023. CI
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023. CI
Youcare Pharmaceutical Group Co., Ltd.(XSSC:688658) added to S&P Global BMI Index CI
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Youcare Pharma's Cefoperazone Sodium Sulbactam Sodium for Injection Passes Regulatory Evaluation MT
Tranche Update on Youcare Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on June 25, 2023. CI
Youcare Pharma to Repurchase Up to 200 Million Yuan Shares MT
Youcare Pharmaceutical Group Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. CI
Youcare Pharmaceutical Group Co., Ltd. authorizes a Buyback Plan. CI
Youcare Pharma’s Inhaled COVID-19 Drug Candidate Cleared For Clinical Trial in Australia MT
Youcare Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chart Youcare Pharmaceutical Group Co., Ltd.
More charts
Youcare Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the development and production of chemical drugs. The Company’s products are mainly cardiovascular and cerebrovascular drugs, digestive system drugs, diabetes drugs and anti-infective drugs, including ginkgo biloba extract injection, gastrodin injection, lansoprazole for injection, and omeprazole enteric-coated capsules , metformin hydrochloride sustained-release tablets, cefuroxime sodium for injection and ceftriaxone sodium for injection, etc. The Company conducts its businesses within the China market and to overseas markets.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
17.06 CNY
Average target price
28 CNY
Spread / Average Target
+64.13%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688658 Stock
  4. News Youcare Pharmaceutical Group Co., Ltd.
  5. Youcare Pharmaceutical’s Antibiotic Passes Generic Drug Evaluation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW